Cita APA

Lu, P., Hsu, J., Keane, C., Fettner, S., Wang, J., Ruperto, N., . . . De Benedetti, F. (2013). PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients. BioMed Central.

Chicago Style Citation

Lu, P., J. Hsu, C. Keane, S. Fettner, J. Wang, N. Ruperto, O. Harari, HI Brunner, i F. De Benedetti. PReS-FINAL-2159: Tocilizumab (TCZ) Dosing in Juvenile Idiopathic Arthritis (JIA): Optimising for Different JIA Type and Body Weight Patients. BioMed Central, 2013.

Cita MLA

Lu, P., et al. PReS-FINAL-2159: Tocilizumab (TCZ) Dosing in Juvenile Idiopathic Arthritis (JIA): Optimising for Different JIA Type and Body Weight Patients. BioMed Central, 2013.